The tools used by Murphy, an associate professor of biomedical engineering and orthopedics and rehabilitation at University of Wisconsin-Madison, however, are proteins, which are vastly more flexible than socket wrenches -- and roughly 100 million times smaller. One end of his modular tool may connect to bone, while the other end may stimulate the growth of bone, blood vessels or cartilage.
On February 4th and 6th, at the Orthopedic Research Society meeting in San Francisco, Darilis Suarez-Gonzalez and Jae Sung Lee of the Murphy lab are reporting that orthopedic implants "dip-coated" with modular growth factors can stimulate bone and blood vessel growth in sheep.
For many years, medical scientists have been fascinated by growth factors -- proteins that can stimulate tissues to grow. But these factors can be too effective or not specific enough, leading to cancer rather than the controlled growth needed for healing.
Murphy wants to start applying the manifold benefits of the modular approach to healing or regenerating bone, tendon, and ligaments, and in particular to replacement surgery after an artificial joint has loosened or failed. Temporarily stimulating bones to grow by placing growth factors near the new implant could shorten healing time and ensure a good, tight fit.
The approach could also be used for reattaching ligaments to bone after sports injuries and healing large bone defects during spinal fusion, facial reconstruction or trauma. In this work, Murphy collaborates with two associate professors of orthopedics and rehabilitation at the School of Medicine and Public Health. "Ben Graf focuses on knee injuries in sports medicine," he says, "and David Goodspeed, a lieutenant colonel in the Army who has seen blast injuries during multiple tours in Iraq, is working on the kind of major traumatic wound we think is potentially treatable using this approach."
The working end of the modular structure may feature a fragment of a growth factor, but not the entire protein. "Often, you just want the specific regions that activate the signaling pathways, because that can reduce the chances of stimulating unwanted growth, even cancer," he says.
At the other end, Murphy may place an anchoring molecule that binds to the bone and prevents the modular structure from migrating away from the wound.
With the modular approach, he says, "you might be able to stimulate bone formation without the side effects. We are trying to decrease stimulation outside of the bone defect, trying to design these molecules to specifically generate new bone in a defect, and to stay there."
Animal tests, performed in collaboration with Mark Markel, a professor of veterinary medicine, have shown that the bone is denser around the implant, and that the union between the implant and the bone is stronger than produced by state-of-the-art orthopedic techniques. The added growth factors have not been detected elsewhere in the animal, Murphy says.
Engineering each section of the molecule separately allows their properties to be tailored as needed. "We can take similar protein structures and modulate them," Murphy says. "If we want a molecule that binds very strongly to the surface of a bone graft, we can do that. If we want one that releases over controllable time-frames, we can do that as well."
Moving from the lab to the clinic is a major step, and Murphy knows that many hurdles remain. "We have shown that this can work in a large, clinically relevant animal model, but realistically, I don't see this being used in the clinic within the next five years."
Murphy says his approach is inspired by biology without trying to exactly duplicate normal communication between cells and tissues. "We are not interested in specifically mimicking a particular structure or function, but nature uses a variety of fundamental mechanisms during development and regeneration, and we are taking lessons from them and designing synthetic systems to achieve similar outcomes. We are not repeating nature, but we are inspired by nature."
David Tennenbaum, 608-265-8549, firstname.lastname@example.org
William Murphy | EurekAlert!
Maelstroms in the heart
22.02.2018 | Max-Planck-Institut für Dynamik und Selbstorganisation
Decoding the structure of the huntingtin protein
22.02.2018 | Max-Planck-Institut für Biochemie
Quantum computers may one day solve algorithmic problems which even the biggest supercomputers today can’t manage. But how do you test a quantum computer to...
For the first time, a team of researchers at the Max-Planck Institute (MPI) for Polymer Research in Mainz, Germany, has succeeded in making an integrated circuit (IC) from just a monolayer of a semiconducting polymer via a bottom-up, self-assembly approach.
In the self-assembly process, the semiconducting polymer arranges itself into an ordered monolayer in a transistor. The transistors are binary switches used...
Breakthrough provides a new concept of the design of molecular motors, sensors and electricity generators at nanoscale
Researchers from the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague), Institute of Physics of the CAS (IP CAS) and Palacký University...
For photographers and scientists, lenses are lifesavers. They reflect and refract light, making possible the imaging systems that drive discovery through the microscope and preserve history through cameras.
But today's glass-based lenses are bulky and resist miniaturization. Next-generation technologies, such as ultrathin cameras or tiny microscopes, require...
Scientists from the University of Zurich have succeeded for the first time in tracking individual stem cells and their neuronal progeny over months within the intact adult brain. This study sheds light on how new neurons are produced throughout life.
The generation of new nerve cells was once thought to taper off at the end of embryonic development. However, recent research has shown that the adult brain...
15.02.2018 | Event News
13.02.2018 | Event News
12.02.2018 | Event News
22.02.2018 | Business and Finance
22.02.2018 | Health and Medicine
22.02.2018 | Life Sciences